{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:47:08Z","timestamp":1715597228956},"reference-count":33,"publisher":"Japanese Society of Hypertension","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1291\/hypres.28.141","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T05:57:44Z","timestamp":1130479064000},"page":"141-146","source":"Crossref","is-referenced-by-count":16,"title":["Low Adiponectin Level in Young Normotensive Men with a Family History of Essential Hypertension"],"prefix":"10.1291","volume":"28","author":[{"given":"Masato","family":"FURUHASHI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"URA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhiro","family":"HIGASHIURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"MIYAZAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"MURAKAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"HYAKUKOKU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"SHIMAMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.26746"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.0587"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.18.10697"},{"issue":"4","key":"4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/oxfordjournals.jbchem.a021483","volume":"120","author":"NAKANO Y","year":"1996","ISSN":"http:\/\/id.crossref.org\/issn\/0021-924X","issn-type":"print"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.0255"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ouchi N, Kihara S, Arita Y, et al<\/i>: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation<\/i> 1999; 100<\/b>: 2473-2476.","DOI":"10.1161\/01.CIR.100.25.2473"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.5.1930"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hotta K, Funahashi T, Arita Y, et al<\/i>: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol<\/i> 2000; 20<\/b>: 1595-1599.","DOI":"10.1161\/01.ATV.20.6.1595"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Furuhashi M, Ura N, Moniwa N, et al<\/i>: Possible impairment of transcardiac utilization of adiponectin in patients with diabetes mellitus. Diabetes Care<\/i> 2004; 27<\/b>: 2217-2221.","DOI":"10.2337\/diacare.27.9.2217"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000078490.59735.6E"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Furuhashi M, Ura N, Takizawa H, et al<\/i>: Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens<\/i> 2004; 22<\/b>: 1977-1982.","DOI":"10.1097\/00004872-200410000-00021"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1038\/90984"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000042707.50032.19"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.705"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Reaven GM: Role of insulin resistance in human disease. Diabetes<\/i> 1988; 37<\/b>: 1595-1607.","DOI":"10.2337\/diab.37.12.1595"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.149.7.1514"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care<\/i> 1991; 14<\/b>: 173-194.","DOI":"10.2337\/diacare.14.3.173"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iimura O: Insulin resistance and hypertension in Japanese. Hypertens Res<\/i> 1996; 19<\/b> (Suppl) 1: S1-S8.","DOI":"10.1291\/hypres.19.SupplementI_S1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lind L, Berne C, Lithell H: Prevalence of insulin resistance in essential hypertension. J Hypertens<\/i> 1995; 13<\/b>: 1457-1462.","DOI":"10.1097\/00004872-199512000-00012"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Facchini F, Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM: Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens<\/i> 1992; 5<\/b>: 694-699.","DOI":"10.1093\/ajh\/5.10.694"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohno Y, Suzuki H, Yamakawa H, Nakamura M, Otsuka K, Saruta T: Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens<\/i> 1993; 11<\/b>: 421-426.","DOI":"10.1097\/00004872-199304000-00013"},{"issue":"6896","key":"22","first-page":"92","volume":"307","year":"1993","ISSN":"http:\/\/id.crossref.org\/issn\/0959-8146","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Endre T, Mattiasson I, Hulthen UL, Lindgarde F, Berglund G: Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension. J Hypertens<\/i> 1994; 12<\/b>: 81-88.","DOI":"10.1097\/00004872-199401000-00012"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Grandi AM, Gaudio G, Fachinetti A, et al<\/i>: Hyperinsulinemia, family history of hypertension, and essential hypertension. Am J Hypertens<\/i> 1996; 9<\/b>: 732-738.","DOI":"10.1016\/0895-7061(96)00095-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Grandi AM, Gaudio G, Fachinetti A, et al<\/i>: Insulin sensitivity in obese normotensive adults: influence of family history of hypertension. Int J Obes Relat Metab Disord<\/i> 1998; 22<\/b>: 910-914.","DOI":"10.1038\/sj.ijo.0800693"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Pellme F, Smith U, Funahashi T, et al<\/i>: Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients. Diabetes<\/i> 2003; 52<\/b>: 1182-1186.","DOI":"10.2337\/diabetes.52.5.1182"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol<\/i> 1979; 237<\/b>: E214-E223.","DOI":"10.1152\/ajpendo.1979.237.3.E214"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Maeda N, Takahashi M, Funahashi T, et al<\/i>: PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes<\/i> 2001; 50<\/b>: 2094-2099.","DOI":"10.2337\/diabetes.50.9.2094"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yang WS, Jeng CY, Wu TJ, et al<\/i>: Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care<\/i> 2002; 25<\/b>: 376-380.","DOI":"10.2337\/diacare.25.2.376"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Miyazaki Y, Hirata A, Murakami H, et al<\/i>: Effects of aging on the insulin actions for the glucose metabolism and renal function in normotensives and essential hypertensives. Am J Hypertens<\/i> 1998; 11<\/b>: 1056-1064.","DOI":"10.1016\/S0895-7061(98)00113-7"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kazumi T, Kawaguchi A, Sakai K, Hirano T, Yoshino G: Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care<\/i> 2002; 25<\/b>: 971-976.","DOI":"10.2337\/diacare.25.6.971"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-38248"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yamamoto Y, Hirose H, Saito I, et al<\/i>: Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci<\/i> 2002; 103<\/b>: 137-142.","DOI":"10.1042\/cs1030137"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T14:41:23Z","timestamp":1586529683000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.28.141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.28.141","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}